PURPOSE: To investigate associations between the androgen receptor (AR) polymorphisms as CAG repeats, GGC repeats and c.211G>A polymorphism and the risk of preeclampsia. METHODS: The AR polymorphisms were experienced in 184 preeclamptic patients and 190 normal pregnancies and analyzed by multiple logistic regression. RESULTS: Women with GGC repeats>16 were more frequently observed in preeclampsia, compared to those with GGC repeats≤16 [adjOR (95% CI): 3.64 (1.71-6.23)]. However, no significant differences were observed between the two groups with respect to CAG repeats. The genotypic and allelic frequencies of c.211G>A variant were significantly higher in cases than in controls (P < 0.05 for both). In the combined distribution of these polymorphisms, the highest risk of preeclampsia was found among women with the haplotype as CAG > 20/GA/GGC >16 [adjOR (95% CI): 4.26 (1.92-12.23)]. CONCLUSIONS: Our findings suggest that longer GGC repeats and c.211G>A variant in the AR gene are associated with increased susceptibility to the risk of preeclampsia.
PURPOSE: To investigate associations between the androgen receptor (AR) polymorphisms as CAG repeats, GGC repeats and c.211G>A polymorphism and the risk of preeclampsia. METHODS: The AR polymorphisms were experienced in 184 preeclamptic patients and 190 normal pregnancies and analyzed by multiple logistic regression. RESULTS:Women with GGC repeats>16 were more frequently observed in preeclampsia, compared to those with GGC repeats≤16 [adjOR (95% CI): 3.64 (1.71-6.23)]. However, no significant differences were observed between the two groups with respect to CAG repeats. The genotypic and allelic frequencies of c.211G>A variant were significantly higher in cases than in controls (P < 0.05 for both). In the combined distribution of these polymorphisms, the highest risk of preeclampsia was found among women with the haplotype as CAG > 20/GA/GGC >16 [adjOR (95% CI): 4.26 (1.92-12.23)]. CONCLUSIONS: Our findings suggest that longer GGC repeats and c.211G>A variant in the AR gene are associated with increased susceptibility to the risk of preeclampsia.
Authors: Shin Young Kim; Ji Hyae Lim; So Yeon Park; Jae Hyug Yang; Moon Young Kim; Min Hyoung Kim; Hyun Mee Ryu Journal: Am J Reprod Immunol Date: 2009-12-31 Impact factor: 3.886
Authors: Ana González; F Javier Dorta; Germán Rodriguez; Buenaventura Brito; M A Del Cristo Rodríguez; Antonio Cabrera; Juan C Díaz-Chico; Ricardo Reyes; Armando Aguirre-Jaime; B Nicolás Díaz-Chico Journal: Eur J Cancer Date: 2007-08-28 Impact factor: 9.162
Authors: Ellane R Cleys; Jennifer L Halleran; Vanessa A Enriquez; Juliano C da Silveira; Rachel C West; Quinton A Winger; Russell V Anthony; Jason E Bruemmer; Colin M Clay; Gerrit J Bouma Journal: PLoS One Date: 2015-02-12 Impact factor: 3.240
Authors: Ji Hyae Lim; Yu-Jung Kang; Hye Jin Bak; Mi Sun Kim; Hyun Jung Lee; Dong Wook Kwak; You Jung Han; Moon Young Kim; Hyeyeon Boo; Shin Young Kim; Hyun Mee Ryu Journal: Clin Epigenetics Date: 2020-08-24 Impact factor: 6.551